In colorectal cancer patients, serum ESM-1 levels were significantly higher than those in healthy controls, and positively correlated with histological differentiation, depth of tumor invasion, TNM stage and lymph node metastasis [16]. This evidence concerns the gene ESM1 and metastatic malignant neoplasm in the lymph nodes.